menu

Oligonucleotide Synthesis Market

Schedule Call

Oligonucleotide Synthesis Market

Oligonucleotide Synthesis Market by Product (Oligonucleotides, Equipment/Synthesizer), Application (PCR Assays and Panels, Sequencing, PCR Primers), End-user (Pharmaceutical - Biotechnology Companies, Academic Research Institutes) – Global Outlook & Forecast 2023-2031

GR - 844256 Category: Biotechnology

Number of pages: 100  |  Report Format: PDF  |  Published date: 02 March, 2023

Historical Years – 2021  |  Base Year – 2022  |  Forecasted Years – 2023-2031


Oligonucleotide Synthesis Market Scope

Report Attribute

Details

Market size value in 2022

US$ 4.94 billion

Revenue forecast in 2031

US$ 14.19 billion

Growth Rate

CAGR of 12.4% from 2023 to 2031

Base year for estimation

2022

Forecast Period

2023-2031

Historical Year

2021

Segments covered

Product, Application, End-user, and Region

Regional scope

North America, Europe, Asia Pacific, and the Rest of the World (ROW)

Report Overview

According to the deep-dive market assessment study by Growth Plus Reports, the global oligonucleotide synthesis market was valued at US$ 4.94 billion in 2022 and is expected to register a revenue CAGR of 12.4% to reach US$ 14.19 billion by 2031.  

Market Fundamentals

Oligonucleotides are single or double stranded nucleic acid segments that are linked together to form single chain biological polymers. Oligonucleotides can be synthesized enzymatically through the cleavage of larger biomolecules or chemically targeted synthesis. In the latter scenario, nucleoside phosphoramidites, a crucial monomeric component of oligonucleotides, are created through the chemical process known as organonucleotide synthesis. Nucleoside phosphoramidites themselves are derivatives of natural or synthetic nucleosides.

[6657567]

Market Dynamics

The rising advancement in genomics sequencing, such as NGS technology, has helped to lower the overall price of sequencing, which is one of the major driving factors of the global oligonucleotide synthesis market. Moreover, the increased government initiatives to support genome sequencing projects and change the regulatory environment around genetic testing are also propelling the global market growth. There is a rise in the demand for personalized gene sequences to determine the best treatment for patients. Similarly, there is a rise in the use of oligonucleotides in therapies for different chronic diseases, including cancer, infection, and rare diseases, boosting the growth of the global market. Additionally, the rise in the application of oligonucleotides in molecular diagnostics with fewer side effects of the oligonucleotide products increases the demand for oligonucleotide synthesis. The major companies increasing their investment in research and development and the rising number of pipeline drugs are also pivotal in the growth of the global oligonucleotide synthesis market. However, the high cost of oligonucleotide synthesis is the major restriction of the worldwide market. Moreover, a lack of skilled professionals and researchers in developing countries is also hindering the growth of the global market.

Market Ecosystem

The global oligonucleotide synthesis market has been analyzed from four perspectives: Product, Application, End-user, and Region.

Oligonucleotide Synthesis Market by Product

[865755]

Based on product type, the global oligonucleotide synthesis market is segmented into oligonucleotides, equipment/synthesizer, reagents, and services.

The oligonucleotides segment dominates the global oligonucleotide synthesis market, with the largest market revenue share in 2022. The oligonucleotides segment is further sub-segmented into product and nucleic acid types. The large share of oligonucleotides can be attributed to the rising application of oligonucleotides in research, disease diagnosis, and therapeutics. Moreover, oligonucleotides are used as primers in gene expression and disease processes, pivotal in segment growth. The increase in research and development in molecular biology and synthetic biology, where oligonucleotides are vastly used, is thus increasing the demand for oligonucleotides. The rising use of oligonucleotides in genetic testing to forensic research is also anticipated to propel the segment growth. 

Oligonucleotide Synthesis Market by Application

Based on application, the global oligonucleotide synthesis market is segmented into PCR assays and panels, sequencing, PCR primers, DNA microarrays, fluorescence in situ hybridization (FISH), antisense oligonucleotides, and other applications.

The PCR primers segment holds the largest market revenue share of the global oligonucleotide synthesis market in 2022. The dominating share of the PCR primers segment can largely be attributed to the increased application of PCR in drug development. Oligonucleotides are the most commonly used primer in a PCR. Moreover, the research on gene expression and disease processes has been transformed by using oligonucleotides as primers which propel the segment growth. In molecular biology, PCR has also been employed to help researchers clone and sequence genes to find mutations, increasing the demand for PCR primers. Additionally, the rise in the research on oligonucleotide-based therapeutics, including antisense therapeutics, DNA vaccines, and anti-viral agents, is also boosting segment growth. 

Oligonucleotide Synthesis Market by End-user

Based on end-users, the global oligonucleotide synthesis market is segmented into pharmaceutical-biotechnology companies, academic research institutes, diagnostic laboratories. 

The pharmaceutical-biotechnology companies segment leads the global oligonucleotide synthesis market with the largest market revenue share in 2022. The pharma and biotech companies are focusing on developing novel drugs; thus, there is a rise in the utilization of oligonucleotides. Moreover, oligonucleotides provide an efficient drug administration route and effective treatment mode, boosting the market growth. Additionally, the use of oligonucleotides is reducing the overall price of the drug development procedure, increasing the demand for oligonucleotides in the pharma and biotech sectors. 

Oligonucleotide Synthesis Market by Region

Based on region, the global oligonucleotide synthesis market has been segmented into North America, Europe, Asia Pacific, and the Rest of the World. 

North America dominated the global oligonucleotide synthesis market in 2022, followed by Europe. Asia Pacific is the fastest-growing regional market. The rise in the overall expenditure for regional research and development is boosting regional growth. The presence of the top manufacturers and research institutes in the region also propels regional growth. Additionally, the government organizations in the region are taking the initiative to promote R&D for the treatment of genetic diseases is also anticipated to fuel regional growth. 
The demand for oligonucleotide synthesis in Asia is high due to the increasing number of research and development activities in the pharmaceutical and biotechnology industries. Oligonucleotide synthesis is used to develop new drugs, diagnostics, and therapeutics. The growing demand for personalized medicine and gene therapy is also driving the growth of the market. In addition, the increasing prevalence of diseases such as cancer, cardiovascular diseases, and neurological disorders is also driving the demand for oligonucleotide synthesis in the Asia Pacific region. 

Moreover, the increasing number of clinical trials for oligonucleotide synthesis is also driving the demand for the process in the region. The increasing number of collaborations between key players is also driving the demand for oligonucleotide synthesis in the Asia Pacific region. For instance, in 2020, Bio-Synthesis Inc. and DNA2.0 Inc. announced a collaboration to develop a new platform for oligonucleotide synthesis. The collaboration is expected to reduce the cost of oligonucleotide synthesis. Furthermore, the increasing investment in the healthcare sector is also driving the demand for oligonucleotide synthesis in the region. 

Governments in the Asia Pacific region are investing heavily in the healthcare sector to improve the quality of healthcare services. This is expected to create opportunities for the development of new drugs and diagnostics, which in turn is expected to drive the demand for oligonucleotide synthesis in the region. In addition, the increasing number of mergers and acquisitions between key players is also driving the demand for oligonucleotide synthesis in the region. For instance, in 2020, Eurofins Genomics acquired ATDBio Ltd. The acquisition is expected to strengthen Eurofins Genomics’ position in the oligonucleotide synthesis market. 

The increasing awareness about the applications of oligonucleotide synthesis is also driving the demand for the process in the region. For instance, oligonucleotide synthesis is used in the development of vaccines for the treatment of various diseases. This is expected to create opportunities for the development of new vaccines, which in turn is expected to drive the demand for oligonucleotide synthesis in the region. The increasing demand for oligonucleotide synthesis in the Asia Pacific region is expected to create lucrative opportunities for the market. Key players in the market are focusing on developing innovative solutions for oligonucleotide synthesis. This is expected to fuel the growth of the market in the region. 

Competitive Landscape

Some prominent players operating in the oligonucleotide synthesis market are:

Strategic Developments

  • In October 2022, Telesis Bio and Cellibre announced collaboration for optimizing the development and validation of Telesis Bio’s BioXp Digital-to-Biological Converter (DBC) instrument for fully automated manufacturing of on-demand CRISPR-Cas9 guide RNA (gRNA) for genome editing. By integrating Telesis Bio’s short oligonucleotide ligation assembly (SOLA) enzymatic DNA synthesis (EDS) technology directly onto its recently released BioXp® 9600 system, this instrument will empower scientists with same-day design and build capabilities for their guide RNAs, and without the need to order custom reagents.

Frequently Asked Questions About This Report

The global oligonucleotide synthesis market is estimated to reach US$ 14.19 billion in 2031.

The key competitors in the global oligonucleotide synthesis market are Thermo Fisher Scientific Inc., Merck KGaA, GE Healthcare, Agilent Technologies, Eurofins Scientific SE, Integrated DNA Technologies Inc. (Part of Danaher Corporation), Eurogentec S.A., GeneDesign Inc., LGC Biosearch Technologies, Bio-synthesis Inc., TriLink BioTechnologies LLC, and BioAutomation among others.

Oligonucleotides, or oligos, are single or double stranded nucleic acid segments linked together to form single chain biological polymers. Oligonucleotides can be synthesized enzymatically though the cleavage of larger biomolecules or through chemically targeted synthesis.

The oligonucleotides segment dominates the global market with the largest market share of the global market.

The major market players are collaborating to develop novel products related to oligonucleotides.

Table of Content

  1. INTRODUCTION
    1. Market Ecosystem
    2. Timeline Under Consideration
      1. Historical Years – 2021
      2. Base Year – 2022
      3. Forecast Years – 2023 to 2031
    3. Currency Used in the Report
  2. RESEARCH METHODOLOGY 
    1. Research Approach
    2. Data Collection Methodology
    3. Data Products
      1. Secondary Products 
      2. Primary Products 
    4. Market Estimation Approach
      1. Bottom Up
      2. Top Down 
    5. Market Forecasting Model
    6. Limitations and Assumptions
  3. PREMIUM INSIGHTS
    1. Current Market Trends (COVID-19 Perspective)
    2. Key Players & Competitive Positioning (2022) 
    3. Regulatory Landscape
    4. Reimbursements
  4. MARKET DYNAMICS
    1. Drivers
    2. Restraints/Challenges
    3. Opportunities
  5. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET - ANALYSIS & FORECAST, BY PRODUCT
    1. Natural Oligonucleotides
      1. By Product Type
        1. Array-based Oligos
        2. Column-based Oligos
      2. By Nucleic Acid Type
        1. DNA
        2. RNA
    2. Equipment/Synthesizer
    3. Reagents
    4. Services
      1. Oligo Synthesis
      2. Purification
      3. Modification
  6. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET - ANALYSIS & FORECAST, BY APPLICATION
    1. PCR Assays and Panels
    2. Sequencing
    3. PCR Primers
    4. DNA Microarrays
    5. Fluorescence In Situ Hybridization (FISH)
    6. Antisense Oligonucleotides
    7. Other Applications
  7. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET - ANALYSIS & FORECAST, BY END-USER
    1. Pharmaceutical - Biotechnology Companies
    2. Academic Research Institutes
    3. Diagnostic Laboratories
  8. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET - ANALYSIS & FORECAST, BY REGION
    1. North America Oligonucleotide Synthesis Market
      1. North America Oligonucleotide Synthesis Market, by Product 
      2. North America Oligonucleotide Synthesis Market, by Application
      3. North America Oligonucleotide Synthesis Market, by End-user
      4. North America Oligonucleotide Synthesis Market, by Country
        1. U.S.
          1. U.S. Oligonucleotide Synthesis Market, by Product 
          2. U.S. Oligonucleotide Synthesis Market, by Application
          3. U.S. Oligonucleotide Synthesis Market, by End-user
        2. Canada
          1. Canada Oligonucleotide Synthesis Market, by Product 
          2. Canada Oligonucleotide Synthesis Market, by Application
          3. Canada Oligonucleotide Synthesis Market, by End-user
    2. Europe Oligonucleotide Synthesis Market
      1. Europe Oligonucleotide Synthesis Market, by Product 
      2. Europe Oligonucleotide Synthesis Market, by Application 
      3. Europe Oligonucleotide Synthesis Market, by End-user
      4. Europe Oligonucleotide Synthesis Market, by Country/Region
        1. Germany
          1. Germany Oligonucleotide Synthesis Market, by Product 
          2. Germany Oligonucleotide Synthesis Market, by Application
          3. Germany Oligonucleotide Synthesis Market, by End-user 
        2. U.K.
          1. U.K. Oligonucleotide Synthesis Market, by Product 
          2. U.K. Oligonucleotide Synthesis Market, by Application
          3. U.K. Oligonucleotide Synthesis Market, by End-user 
        3. France
          1. France Oligonucleotide Synthesis Market, by Product 
          2. France Oligonucleotide Synthesis Market, by Application
          3. France Oligonucleotide Synthesis Market, by End-user
        4. Spain
          1. Spain Oligonucleotide Synthesis Market, by Product 
          2. Spain Oligonucleotide Synthesis Market, by Application
          3. Spain Oligonucleotide Synthesis Market, by End-user 
        5. Italy
          1. Italy Oligonucleotide Synthesis Market, by Product 
          2. Italy Oligonucleotide Synthesis Market, by Application
          3. Italy Oligonucleotide Synthesis Market, by End-user 
        6. Rest of Europe 
          1. Rest of Europe Oligonucleotide Synthesis Market, by Product 
          2. Rest of Europe Oligonucleotide Synthesis Market, by Application
          3. Rest of Europe Oligonucleotide Synthesis Market, by End-user 
    3. Asia Pacific Oligonucleotide Synthesis Market
      1. Asia Pacific Oligonucleotide Synthesis Market, by Product 
      2. Asia Pacific Oligonucleotide Synthesis Market, by Application
      3. Asia Pacific Oligonucleotide Synthesis Market, by End-user
      4. Asia Pacific Oligonucleotide Synthesis Market, by Country/Region
        1. China
          1. China Oligonucleotide Synthesis Market, by Product 
          2. China Oligonucleotide Synthesis Market, by Application
          3. China Oligonucleotide Synthesis Market, by End-user 
        2. Japan
          1. Japan Oligonucleotide Synthesis Market, by Product 
          2. Japan Oligonucleotide Synthesis Market, by Application 
          3. Japan Oligonucleotide Synthesis Market, by End-user
        3. India
          1. India Oligonucleotide Synthesis Market, by Product 
          2. India Oligonucleotide Synthesis Market, by Application
          3. India Oligonucleotide Synthesis Market, by End-user 
        4. South Korea
          1. South Korea Oligonucleotide Synthesis Market, by Product 
          2. South Korea Oligonucleotide Synthesis Market, by Application
          3. South Korea Oligonucleotide Synthesis Market, by End-user
        5. Australia
          1. Australia Oligonucleotide Synthesis Market, by Product 
          2. Australia Oligonucleotide Synthesis Market, by Application
          3. Australia Oligonucleotide Synthesis Market, by End-user 
        6. Rest of Asia Pacific
          1. Rest of Asia Pacific Oligonucleotide Synthesis Market, by Product 
          2. Rest of Asia Pacific Oligonucleotide Synthesis Market, by Application
          3. Rest of Asia Pacific Oligonucleotide Synthesis Market, by End-user 
    4. Latin America Oligonucleotide Synthesis Market
      1. Latin America Oligonucleotide Synthesis Market, by Product 
      2. Latin America Oligonucleotide Synthesis Market, by Application
      3. Latin America Oligonucleotide Synthesis Market, by End-user 
      4. Latin America Oligonucleotide Synthesis Market, by Country/ Region
        1. Brazil
          1. Brazil Oligonucleotide Synthesis Market, by Product 
          2. Brazil Oligonucleotide Synthesis Market, by Application
          3. Brazil Oligonucleotide Synthesis Market, by End-user 
        2. Mexico
          1. Mexico Oligonucleotide Synthesis Market, by Product 
          2. Mexico Oligonucleotide Synthesis Market, by Application 
          3. Mexico Oligonucleotide Synthesis Market, by End-user
        3. Argentina
          1. Argentina Oligonucleotide Synthesis Market, by Product 
          2. Argentina Oligonucleotide Synthesis Market, by Application
          3. Argentina Oligonucleotide Synthesis Market, by End-user 
        4. Rest of Latin America
          1. Rest of Latin America Oligonucleotide Synthesis Market, by Product 
          2. Rest of Latin America Oligonucleotide Synthesis Market, by Application 
          3. Rest of Latin America Oligonucleotide Synthesis Market, by End-user
    5. Middle East & Africa Oligonucleotide Synthesis Market
      1. Middle East & Africa Oligonucleotide Synthesis Market, by Product 
      2. Middle East & Africa Oligonucleotide Synthesis Market, by Application
      3. Middle East & Africa Oligonucleotide Synthesis Market, by End-user 
      4. Middle East & Africa Oligonucleotide Synthesis Market, by Country/ Region
        1. GCC Countries
          1. GCC Countries Oligonucleotide Synthesis Market, by Product 
          2. GCC Countries Oligonucleotide Synthesis Market, by Application
          3. GCC Countries Oligonucleotide Synthesis Market, by End-user 
        2. South Africa
          1. South Africa Oligonucleotide Synthesis Market, by Product 
          2. South Africa Oligonucleotide Synthesis Market, by Application 
          3. South Africa Oligonucleotide Synthesis Market, by End-user
        3. Rest of Middle East & Africa
          1. Rest of Middle East & Africa Oligonucleotide Synthesis Market, by Product 
          2. Rest of Middle East & Africa Oligonucleotide Synthesis Market, by Application
          3. Rest of Middle East & Africa Oligonucleotide Synthesis Market, by End-user 
  9. COMPANY PROFILES         
    1. Thermo Fisher Scientific Inc.
      1. Business Snapshot 
      2. Products Offered
      3. Financial Details
      4. Strategic Development
    2. Merck KGaA
    3. GE Healthcare
    4. Agilent Technologies
    5. Eurofins Scientific SE
    6. Integrated DNA Technologies Inc. (Part of Danaher Corporation)
    7. Eurogentec S.A.
    8. GeneDesign Inc.
    9. LGC Biosearch Technologies
    10. Bio-synthesis Inc.
    11. TriLink BioTechnologies LLC
    12. BioAutomation

*Insights on financial performance are subject to the availability of information in the public domain

List of Tables

 

  1. Global Oligonucleotide Synthesis Market, by Product, 2021-2031 (US$ Million)
  2. Global Oligonucleotide Synthesis Market, by Application, 2021–2031 (US$ Million) 
  3. Global Oligonucleotide Synthesis Market, by End-user, 2021–2031 (US$ Million) 
  4. Global Oligonucleotide Synthesis Market, by Region, 2021-2031 (US$ Million) 
  5. North America Oligonucleotide Synthesis Market, by Product, 2021-2031 (US$ Million) 
  6. North America Oligonucleotide Synthesis Market, by Application, 2021–2031 (US$ Million) 
  7. North America Oligonucleotide Synthesis Market, by End-user, 2021–2031 (US$ Million) 
  8. North America Oligonucleotide Synthesis Market, by Country, 2021-2031 (US$ Million) 
  9. U.S. Oligonucleotide Synthesis Market, by Product, 2021-2031 (US$ Million) 
  10. U.S. Oligonucleotide Synthesis Market, by Application, 2021–2031 (US$ Million) 
  11. U.S. Oligonucleotide Synthesis Market, by End-user, 2021–2031 (US$ Million) 
  12. Canada Oligonucleotide Synthesis Market, by Product, 2021-2031 (US$ Million) 
  13. Canada Oligonucleotide Synthesis Market, by Application, 2021–2031 (US$ Million) 
  14. Canada Oligonucleotide Synthesis Market, by End-user, 2021–2031 (US$ Million) 
  15. Europe Oligonucleotide Synthesis Market, by Product, 2021-2031 (US$ Million) 
  16. Europe Oligonucleotide Synthesis Market, by Application, 2021–2031 (US$ Million) 
  17. Europe Oligonucleotide Synthesis Market, by End-user, 2021–2031 (US$ Million) 
  18. Europe Oligonucleotide Synthesis Market, by Country/ Region, 2021-2031 (US$ Million) 
  19. Germany Oligonucleotide Synthesis Market, by Product, 2021-2031 (US$ Million) 
  20. Germany Oligonucleotide Synthesis Market, by Application, 2021–2031 (US$ Million) 
  21. Germany Oligonucleotide Synthesis Market, by End-user, 2021–2031 (US$ Million)
  22. U.K. Oligonucleotide Synthesis Market, by Product, 2021-2031 (US$ Million) 
  23. U.K. Oligonucleotide Synthesis Market, by Application, 2021–2031 (US$ Million) 
  24. U.K. Oligonucleotide Synthesis Market, by End-user, 2021–2031 (US$ Million)
  25. France Oligonucleotide Synthesis Market, by Product, 2021-2031 (US$ Million) 
  26. France Oligonucleotide Synthesis Market, by Application, 2021–2031 (US$ Million) 
  27. France Oligonucleotide Synthesis Market, by End-user, 2021–2031 (US$ Million) 
  28. Italy Oligonucleotide Synthesis Market, by Product, 2021-2031 (US$ Million) 
  29. Italy Oligonucleotide Synthesis Market, by Application, 2021–2031 (US$ Million) 
  30. Italy Oligonucleotide Synthesis Market, by End-user, 2021–2031 (US$ Million) 
  31. Spain Oligonucleotide Synthesis Market, by Product, 2021-2031 (US$ Million) 
  32. Spain Oligonucleotide Synthesis Market, by Application, 2021–2031 (US$ Million) 
  33. Spain Oligonucleotide Synthesis Market, by End-user, 2021–2031 (US$ Million) 
  34. Rest of Europe Oligonucleotide Synthesis Market, by Product, 2021-2031 (US$ Million) 
  35. Rest of Europe Oligonucleotide Synthesis Market, by Application, 2021–2031 (US$ Million) 
  36. Rest of Europe Oligonucleotide Synthesis Market, by End-user, 2021–2031 (US$ Million) 
  37. Asia Pacific Oligonucleotide Synthesis Market, by Product, 2021-2031 (US$ Million) 
  38. Asia Pacific Oligonucleotide Synthesis Market, by Application, 2021–2031 (US$ Million) 
  39. Asia Pacific Oligonucleotide Synthesis Market, by End-user, 2021–2031 (US$ Million) 
  40. Asia Pacific Oligonucleotide Synthesis Market, by Country/ Region, 2021-2031 (US$ Million) 
  41. China Oligonucleotide Synthesis Market, by Product, 2021-2031 (US$ Million) 
  42. China Oligonucleotide Synthesis Market, by Application, 2021–2031 (US$ Million) 
  43. China Oligonucleotide Synthesis Market, by End-user, 2021–2031 (US$ Million) 
  44. Japan Oligonucleotide Synthesis Market, by Product, 2021-2031 (US$ Million) 
  45. Japan Oligonucleotide Synthesis Market, by Application, 2021–2031 (US$ Million) 
  46. Japan Oligonucleotide Synthesis Market, by End-user, 2021–2031 (US$ Million) 
  47. India Oligonucleotide Synthesis Market, by Product, 2021-2031 (US$ Million) 
  48. India Oligonucleotide Synthesis Market, by Application, 2021–2031 (US$ Million) 
  49. India Oligonucleotide Synthesis Market, by End-user, 2021–2031 (US$ Million) 
  50. South Korea Oligonucleotide Synthesis Market, by Product, 2021-2031 (US$ Million) 
  51. South Korea Oligonucleotide Synthesis Market, by Application, 2021–2031 (US$ Million) 
  52. South Korea Oligonucleotide Synthesis Market, by End-user, 2021–2031 (US$ Million) 
  53. Australia Oligonucleotide Synthesis Market, by Product, 2021-2031 (US$ Million) 
  54. Australia Oligonucleotide Synthesis Market, by Application, 2021–2031 (US$ Million) 
  55. Australia Oligonucleotide Synthesis Market, by End-user, 2021–2031 (US$ Million) 
  56. Rest of Asia Pacific Oligonucleotide Synthesis Market, by Product, 2021-2031 (US$ Million) 
  57. Rest of Asia Pacific Oligonucleotide Synthesis Market, by Application, 2021–2031 (US$ Million) 
  58. Rest of Asia Pacific Oligonucleotide Synthesis Market, by End-user, 2021–2031 (US$ Million)
  59. Latin America Oligonucleotide Synthesis Market, by Product, 2021-2031 (US$ Million) 
  60. Latin America Oligonucleotide Synthesis Market, by Application, 2021–2031 (US$ Million) 
  61. Latin America Oligonucleotide Synthesis Market, by End-user, 2021–2031 (US$ Million) 
  62. Latin America Oligonucleotide Synthesis Market, by Country/ Region, 2021–2031 (US$ Million)
  63. Brazil Oligonucleotide Synthesis Market, by Product, 2021-2031 (US$ Million) 
  64. Brazil Oligonucleotide Synthesis Market, by Application, 2021–2031 (US$ Million) 
  65. Brazil Oligonucleotide Synthesis Market, by End-user, 2021–2031 (US$ Million) 
  66. Mexico Oligonucleotide Synthesis Market, by Product, 2021-2031 (US$ Million) 
  67. Mexico Oligonucleotide Synthesis Market, by Application, 2021–2031 (US$ Million) 
  68. Mexico Oligonucleotide Synthesis Market, by End-user, 2021–2031 (US$ Million) 
  69. Argentina Oligonucleotide Synthesis Market, by Product, 2021-2031 (US$ Million) 
  70. Argentina Oligonucleotide Synthesis Market, by Application, 2021–2031 (US$ Million) 
  71. Argentina Oligonucleotide Synthesis Market, by End-user, 2021–2031 (US$ Million) 
  72. Rest of Latin America Oligonucleotide Synthesis Market, by Product, 2021-2031 (US$ Million) 
  73. Rest of Latin America Oligonucleotide Synthesis Market, by Application, 2021–2031 (US$ Million) 
  74. Rest of Latin America Oligonucleotide Synthesis Market, by End-user, 2021–2031 (US$ Million)
  75. Middle East and Africa Oligonucleotide Synthesis Market, by Product, 2021-2031 (US$ Million) 
  76. Middle East and Africa Oligonucleotide Synthesis Market, by Application, 2021–2031 (US$ Million) 
  77. Middle East and Africa Oligonucleotide Synthesis Market, by End-user 2021–2031 (US$ Million)
  78. Middle East and Africa Oligonucleotide Synthesis Market, by Country/ Region, 2021–2031 (US$ Million)
  79. GCC Countries Oligonucleotide Synthesis Market, by Product, 2021-2031 (US$ Million) 
  80. GCC Countries Oligonucleotide Synthesis Market, by Application, 2021–2031 (US$ Million) 
  81. GCC Countries Oligonucleotide Synthesis Market, by End-user, 2021–2031 (US$ Million) 
  82. South Africa Oligonucleotide Synthesis Market, by Product, 2021-2031 (US$ Million) 
  83. South Africa Oligonucleotide Synthesis Market, by Application, 2021–2031 (US$ Million) 
  84. South Africa Oligonucleotide Synthesis Market, by End-user, 2021–2031 (US$ Million) 
  85. Rest of Middle East & Africa Oligonucleotide Synthesis Market, by Product, 2021-2031 (US$ Million) 
  86. Rest of Middle East & Africa Oligonucleotide Synthesis Market, by Application, 2021–2031 (US$ Million) 
  87. Rest of Middle East & Africa Oligonucleotide Synthesis Market, by End-user, 2021–2031 (US$ Million)

List of Figures

 

  1. Oligonucleotide Synthesis Market Ecosystem  
  2. Snapshot of Global Oligonucleotide Synthesis Market, 2021-2031 
  3. Snapshot of Global Oligonucleotide Synthesis Market, by Region, 2021-2031 
  4. Global Oligonucleotide Synthesis Market: COVID-19 Pandemic Impact Assessment 
  5. Global Oligonucleotide Synthesis Market: Key Players & Competitive Positioning (2022) 
  6. Oligonucleotide Synthesis: Market Dynamics 
  7. Global Oligonucleotide Synthesis Market for Natural Oligonucleotides, 2021-2031 (US$ Million) 
  8. Global Oligonucleotide Synthesis Market for By Product Type, 2021-2031 (US$ Million) 
  9. Global Oligonucleotide Synthesis Market for Array-based Oligos, 2021-2031 (US$ Million) 
  10. Global Oligonucleotide Synthesis Market for Column-based Oligos, 2021-2031 (US$ Million) 
  11. Global Oligonucleotide Synthesis Market for By Nucleic Acid Type, 2021-2031 (US$ Million) 
  12. Global Oligonucleotide Synthesis Market for DNA, 2021-2031 (US$ Million) 
  13. Global Oligonucleotide Synthesis Market for RNA, 2021-2031 (US$ Million) 
  14. Global Oligonucleotide Synthesis Market for Equipment/Synthesizer, 2021-2031 (US$ Million)
  15. Global Oligonucleotide Synthesis Market for Reagents, 2021-2031 (US$ Million) 
  16. Global Oligonucleotide Synthesis Market for Services, 2021-2031 (US$ Million) 
  17. Global Oligonucleotide Synthesis Market for Oligo Synthesis, 2021-2031 (US$ Million)
  18. Global Oligonucleotide Synthesis Market for Purification, 2021-2031 (US$ Million)
  19. Global Oligonucleotide Synthesis Market for Modification, 2021-2031 (US$ Million)
  20. Global Oligonucleotide Synthesis Market for PCR Assays And Panels, 2021-2031 (US$ Million)
  21. Global Oligonucleotide Synthesis Market for Sequencing, 2021-2031 (US$ Million)
  22. Global Oligonucleotide Synthesis Market for PCR Primers, 2021-2031 (US$ Million)
  23. Global Oligonucleotide Synthesis Market for DNA Microarrays, 2021-2031 (US$ Million)
  24. Global Oligonucleotide Synthesis Market for Fluorescence In Situ Hybridization (FISH), 2021-2031 (US$ Million)
  25. Global Oligonucleotide Synthesis Market for Antisense Oligonucleotides, 2021-2031 (US$ Million)
  26. Global Oligonucleotide Synthesis Market for Other Applications, 2021-2031 (US$ Million)
  27. Global Oligonucleotide Synthesis Market for Pharmaceutical - Biotechnology Companies, 2021-2031 (US$ Million)
  28. Global Oligonucleotide Synthesis Market for Applications, 2021-2031 (US$ Million)
  29. Global Oligonucleotide Synthesis Market for Academic Research Institutes, 2021-2031 (US$ Million)
  30. Global Oligonucleotide Synthesis Market for Diagnostic Laboratories Institutes, 2021-2031 (US$ Million)
  31. North America Oligonucleotide Synthesis Market, 2021-2031 (US$ Million) 
  32. U.S. Oligonucleotide Synthesis Market, 2021-2031 (US$ Million) 
  33. Canada Oligonucleotide Synthesis Market, 2021-2031 (US$ Million) 
  34. Europe Oligonucleotide Synthesis Market, 2021-2031 (US$ Million) 
  35. Germany Oligonucleotide Synthesis Market, 2021-2031 (US$ Million) 
  36. U.K. Oligonucleotide Synthesis Market, 2021-2031 (US$ Million) 
  37. France Oligonucleotide Synthesis Market, 2021-2031 (US$ Million) 
  38. Italy Oligonucleotide Synthesis Market, 2021-2031 (US$ Million) 
  39. Spain Oligonucleotide Synthesis Market, 2021-2031 (US$ Million) 
  40. Rest of Europe Oligonucleotide Synthesis Market, 2021-2031 (US$ Million) 
  41. Asia Pacific Oligonucleotide Synthesis Market, 2021-2031 (US$ Million) 
  42. China Oligonucleotide Synthesis Market, 2021-2031 (US$ Million) 
  43. Japan Oligonucleotide Synthesis Market, 2021-2031 (US$ Million) 
  44. India Oligonucleotide Synthesis Market, 2021-2031 (US$ Million) 
  45. South Korea Oligonucleotide Synthesis Market, 2021-2031 (US$ Million) 
  46. Australia Oligonucleotide Synthesis Market, 2021-2031 (US$ Million) 
  47. Rest of Asia Pacific Oligonucleotide Synthesis Market, 2021-2031 (US$ Million) 
  48. Latin America Oligonucleotide Synthesis Market, 2021-2031 (US$ Million) 
  49. Brazil Oligonucleotide Synthesis Market, 2021-2031 (US$ Million) 
  50. Mexico Oligonucleotide Synthesis Market, 2021-2031 (US$ Million) 
  51. Argentina Oligonucleotide Synthesis Market, 2021-2031 (US$ Million)
  52. Rest of Latin America Oligonucleotide Synthesis Market, 2021-2031 (US$ Million)
  53. Middle East & Africa Oligonucleotide Synthesis Market, 2021-2031 (US$ Million) 
  54. GCC Countries Oligonucleotide Synthesis Market, 2021-2031 (US$ Million) 
  55. South Africa Oligonucleotide Synthesis Market, 2021-2031 (US$ Million) 
  56. Rest of Middle East & Africa Oligonucleotide Synthesis Market, 2021-2031 (US$ Million)
  57. Thermo Fisher Scientific Inc. Revenue from 2019 Onwards (US$ Million)
  58. Merck KGaA Revenue from 2019 Onwards (US$ Million)
  59. GE Healthcare Revenue from 2019 Onwards (US$ Million)
  60. Agilent Technologies Revenue from 2019 Onwards (US$ Million)
  61. Eurofins Scientific SE Revenue from 2019 Onwards (US$ Million)
  62. Integrated DNA Technologies Inc. (Part of Danaher Corporation) Revenue from 2019 Onwards (US$ Million)
  63. Eurogentec S.A. Revenue from 2019 Onwards (US$ Million)
  64. GeneDesign Inc. Revenue from 2019 Onwards (US$ Million)
  65. LGC Biosearch Technologies Revenue from 2019 Onwards (US$ Million)
  66. Bio-synthesis Inc. Revenue from 2019 Onwards (US$ Million)
  67. TriLink BioTechnologies LLC Revenue from 2019 Onwards (US$ Million)
  68. BioAutomation Revenue from 2019 Onwards (US$ Million)

Single User License
Single User License
Multi User License
Enterprise User License
$4,750.00
Provides access to one user only and should not be shared with other employees within the organization.
Provides access to up to five users within the department or an organization.
Provides access to all the employees in the organization. The report can also be shared with subsidiaries, sister concerns and group entities.
Grants user/users’ access to quantitative data only, which includes but is not restricted to numeric data, tables, and charts as defined by Growth+ Reports.

Using the fundamental research and knowledge services capabilities of GRG Health, Growth Plus Reports may now be tailored based on client needs.

GRG Health's unique GrowthMIX strategy and comprehensive research methodology enable us to provide unique and valuable insights to our clients while uncovering trends that would not be discovered using traditional techniques.

sans

Snehal Deshmukh

Principle Consultant

Speak to analyst